Translational Pathology Core Facility The Translational Pathology (Core) Laboratory (TPL) is designed to meet the needs of basic, clinical, and population scientists who require analysis of human tissues. TPL provides access to formalin-fixed, paraffin embedded tissues from UNC Hospitals, histopathology services, tissue and cell microarrays, morphological evaluation, morphology-based assays (immunohistochemistry, immunofluorescence, in-situ hybridization, and fluorescence in-situ hybridization), assay development &training, and digital imaging and image analysis for spatial quantification of molecular analytes in intact specimens. TPL is led by Drs. C Ryan Miller (Faculty Director), a leader in translational research and molecular analyses of tissues, and Nana Nikolaishvili-Feinberg (Facility Director), a researcher with experience in all morphological assays and digital image analyses. The LCCC has made significant investments in the TPL to expand services, to purchase forward-looking equipment, to increase capacity through additional staffing, and to develop informatics infrastructure to facilitate case identification, workflow improvements, and integration of digital images and quantitative image analysis data. The latter will allow integration of data from morphology-based assays with those from OMICS technologies. Core use expanded significantly in 2007-2009, in capacity and total service units performed. This year, 51 Pis from eight different LCCC research programs and 36 clinical trials utilized the Core. In 2009, total use was 29,975 service units (80% LCCC members). For 2010, the Center requests $175,126 for personnel and other expenses to support this Core, a 63% increase from 2009, to be allocated towards additional personnel and maintenance contract costs for both existing and newly acquired equipment. Access to and utilization of this core facility will promote the translation of basic science findings to human cancers and permit clinical investigators to perform innovative clinical trials using molecular correlates and endpoints. It will serve population scientists with molecular epidemiology studies on large numbers of samples that require morphological evaluation and assays. Future plans include acquisition of additional automated image analysis equipment and informatics integration with the Bioinformatics Core databases through the LCCC Data Warehouse.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-37
Application #
8392178
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-12-01
Budget End
2013-11-30
Support Year
37
Fiscal Year
2013
Total Cost
$235,108
Indirect Cost
$72,662
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Joseph, Sarah B; Arrildt, Kathryn T; Sturdevant, Christa B et al. (2015) HIV-1 target cells in the CNS. J Neurovirol 21:276-89
Sikov, William M; Berry, Donald A; Perou, Charles M et al. (2015) Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (A J Clin Oncol 33:13-21
Blazer, Marlo; Wu, Christina; Goldberg, Richard M et al. (2015) Neoadjuvant modified (m) FOLFIRINOX for locally advanced unresectable (LAPC) and borderline resectable (BRPC) adenocarcinoma of the pancreas. Ann Surg Oncol 22:1153-9
Knight, E R W; Patel, E Y; Flowers, C A et al. (2015) ASC deficiency suppresses proliferation and prevents medulloblastoma incidence. Oncogene 34:394-402
Dellon, Evan S; Speck, Olga; Woodward, Kimberly et al. (2015) Distribution and variability of esophageal eosinophilia in patients undergoing upper endoscopy. Mod Pathol 28:383-90
Qi, Qibin; Kilpeläinen, Tuomas O; Downer, Mary K et al. (2014) FTO genetic variants, dietary intake and body mass index: insights from 177,330 individuals. Hum Mol Genet 23:6961-72
Jha, Deepak Kumar; Strahl, Brian D (2014) An RNA polymerase II-coupled function for histone H3K36 methylation in checkpoint activation and DSB repair. Nat Commun 5:3965
Guo, Shutao; Lin, C Michael; Xu, Zhenghong et al. (2014) Co-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation. ACS Nano 8:4996-5009
Clark, Martha A; Goheen, Morgan M; Spidale, Nicholas A et al. (2014) RBC barcoding allows for the study of erythrocyte population dynamics and P. falciparum merozoite invasion. PLoS One 9:e101041
Zhang, Weihe; DeRyckere, Deborah; Hunter, Debra et al. (2014) UNC2025, a potent and orally bioavailable MER/FLT3 dual inhibitor. J Med Chem 57:7031-41

Showing the most recent 10 out of 292 publications